Pulsed Electromagnetic Field Therapy Improves Osseous Consolidation after High Tibial Osteotomy in Elderly Patients-A Randomized, Placebo-Controlled, Double-Blind Trial.
Patrick ZieglerAndreas K NusslerBenjamin WilbrandKarsten FalldorfFabian SpringerAnne-Kristin FentzGeorg EschenburgAndreas ZieglerUlrich StöckleElke MaurerAtesch AteschrangSteffen SchröterSabrina EhnertPublished in: Journal of clinical medicine (2019)
Extremely low-frequency pulsed electromagnetic field (ELF-PEMF) therapy is proposed to support bone healing after injuries and surgical procedures, being of special interest for elderly patients. This study aimed at investigating the effect of a specific ELF-PEMF, recently identified to support osteoblast function in vitro, on bone healing after high tibial osteotomy (HTO). Patients who underwent HTO were randomized to ELF-PEMF or placebo treatment, both applied by optically identical external devices 7 min per day for 30 days following surgery. Osseous consolidation was evaluated by post-surgical X-rays (7 and 14 weeks). Serum markers were quantified by ELISA. Data were compared by a two-sided t-test (α = 0.05). Device readouts showed excellent therapy compliance. Baseline parameters, including age, sex, body mass index, wedge height and blood cell count, were comparable between both groups. X-rays revealed faster osseous consolidation for ELF-PEMF compared to placebo treatment, which was significant in patients ≥50 years (∆mean = 0.68%/week; p = 0.003). Findings are supported by post-surgically increased bone-specific alkaline phosphatase serum levels following ELF-PEMF, compared to placebo (∆mean = 2.2 µg/L; p = 0.029) treatment. Adverse device effects were not reported. ELF-PEMF treatment showed a tendency to accelerate osseous consolidation after HTO. This effect was stronger and more significant for patients ≥50 years. This ELF-PEMF treatment might represent a promising adjunct to conventional therapy supporting osseous consolidation in elderly patients.
Keyphrases
- double blind
- placebo controlled
- end stage renal disease
- phase iii
- body mass index
- total knee arthroplasty
- chronic kidney disease
- clinical trial
- newly diagnosed
- phase ii
- randomized controlled trial
- prognostic factors
- combination therapy
- squamous cell carcinoma
- radiation therapy
- emergency department
- single cell
- mesenchymal stem cells
- acute coronary syndrome
- artificial intelligence
- deep learning
- replacement therapy
- preterm birth
- weight loss
- data analysis